1. P501 Thiopurine withdrawal in patients with Crohn's disease: the SURESTE study. (15th January 2020) Authors: Sánchez Rodríguez, E; Sánchez Aldehuelo, R; Guardiola, J; Gutiérrez Casbas, A; Domènech, E; Bermejo, F; Van-Domselaar, M; Mesonero Gismero, F; Suris, G; Muñoz Perez, R; Mañosa, M; Jiménez Márquez, L; Algaba García, A; López sanroman, A Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P458 Effectiveness of biological therapy for pouchitis and other inflammatory complications ot the pouch. And the question of a second Anti-TNF after failure? Results from the RESERVO Study of GETECCU. (27th May 2021) Authors: Mesonero Gismero, F; Zabana, Y; Fernández-Clotet, A; Núñez, A; Caballol, B; Sola, A; García, M J; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, L J; Fajardo, I; Torrealba, L; Nájera, R; Sáiz, R M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P372 Effectiveness and safety of immunosuppressants for pouch disorders: results from the RESERVO Study of GETECCU. (27th May 2021) Authors: Mesonero Gismero, F; Zabana, Y; Fernández-Clotet, A; Leo, E; Caballol, B; Núñez, A; García, M J; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, L J; Fajardo, I; Torrealba, L; Nájera, R; Sáiz, R M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P104 Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU. (27th May 2021) Authors: Mesonero Gismero, F; Zabana, Y; Fernández-Clotet, A; Sola, A; Caballol, B; Leo, E; García, M J; Bertoletti, F; Alejandro, M; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, L J; Fajardo, I; Torrealba, L; Nájera, R; Sáiz, R M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU. (27th May 2021) Authors: Zabana Abdo, Y; Marín-Jiménez, I; Rodríguez-Lago, I; Ramírez Esteso, F; Meijilde, S; Ramos, L; Gomollón, F; Muñoz, F; Suris, G; Ortiz de Zárate, J; Huguet, J M; Llaó, J; García-Sepulcre, M; Sierra, M; Durà, M; Estrecha, S; Fuentes Coronel, A; Hinojosa, E; Olivan, L; Iglesias, E Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗